After receiving the ethical approval in Tanzania, NeuroSolve obtained the ethical clearance in Zambia too. The ethical clearance certificate will allow to conduct medical research on Neurocysticercosis also in Zambia.

NeuroSolve is a four-year project funded by the European Commission and EDCTP3, started on May 1, 2023. The African Institutions involved are: University of Dar es Salaam (Tanzania), Sokoine University of Agriculture (Tanzania), University of Zambia (Zambia); the European Institutions are: Universiteit Ghent (Belgium) and R-Evolution Worldwide Srl – Impresa Sociale (Italy), that is also the project Coordinator. NeuroSolve is committed to fight taeniasis/Neurocysticercosis (NCC) disease in Sub-Saharan Africa.

Potrebbe essere un'immagine raffigurante testo

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Biomedical Ethics and Regulatory Capacity Building: International Dialogues

The LiberHetica and BERC-Luso consortia will meet on the 26th March 2021 to discuss about Biomedical Ethics and Regulatory Capacity Building in Sub-Saharan African countries. The LiberHetica and BERC-Luso are two projects funded by

Read More

R-Evolution Worldwide as part of a multidisciplinary team of African and European researchers developed the VectorEnd project.

The increasing urbanization in Africa, paralleled by inadequate environmental sanitation, significantly contributes to the proliferation of Aedes mosquitoes, which transmit many arboviruses, including dengue virus (DENV) and Chikungunya virus (CHIKV). In 

Read More

Gloria Mason, Director for the Liberia National Ethics Review Board and member of the LiberHetica, speaker at international seminars on ethics in data sharing

Proud to have Gloria Mason, Director for the Liberia National Ethics Review Board and member of the LiberHetica (http://liberhetica.org) project in the panel of joint online seminars examining the GFBR

Read More